Tandem Diabetes Care, Inc. (FRA:TD5A)
16.09
+0.15 (0.91%)
At close: Feb 20, 2026
Tandem Diabetes Care Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 90.63 | 69.23 | 58.87 | 172.52 | 71.18 |
Short-Term Investments | 202.03 | 369.1 | 409.04 | 444.38 | 552.63 |
Cash & Short-Term Investments | 292.67 | 438.33 | 467.91 | 616.9 | 623.81 |
Cash Growth | -33.23% | -6.32% | -24.15% | -1.11% | 28.64% |
Receivables | 165.49 | 114.59 | 105.56 | 114.72 | 110.73 |
Inventory | 128.77 | 149.61 | 157.94 | 111.12 | 68.55 |
Prepaid Expenses | 31.22 | 21.97 | 16.59 | 7.24 | 8.43 |
Total Current Assets | 618.14 | 724.49 | 747.99 | 849.98 | 811.52 |
Property, Plant & Equipment | 179.75 | 163.46 | 164.33 | 179.18 | 77.89 |
Long-Term Investments | 60.35 | 74.55 | 10.1 | 16.4 | - |
Other Intangible Assets | 11.72 | 0.93 | 2.78 | 4.63 | 6.64 |
Other Long-Term Assets | 11.15 | 4.24 | 27.46 | 2.6 | 9.09 |
Total Assets | 881.11 | 967.66 | 952.66 | 1,053 | 905.14 |
Accounts Payable | 47.07 | 44.73 | 49.59 | 55.73 | 28.03 |
Accrued Expenses | 99.02 | 84.53 | 56.66 | 48.28 | 60.98 |
Current Portion of Long-Term Debt | 4.9 | 45.47 | - | - | - |
Current Portion of Leases | 19.47 | 18.21 | 17.06 | 13.12 | 9.28 |
Current Unearned Revenue | 9.53 | 11.83 | 43.99 | 18.84 | 10.18 |
Other Current Liabilities | 62.74 | 42.28 | 27.96 | 29.33 | 23.39 |
Total Current Liabilities | 242.72 | 247.05 | 195.26 | 165.29 | 131.86 |
Long-Term Debt | 310.04 | 308.27 | 289.74 | 287.93 | 281.47 |
Long-Term Leases | 114.97 | 106.42 | 113.57 | 123.52 | 23.92 |
Long-Term Unearned Revenue | 8.47 | 10.46 | 13.33 | 16.87 | 16.94 |
Other Long-Term Liabilities | 49.74 | 32.37 | 27.13 | 19.22 | 17.84 |
Total Liabilities | 725.94 | 704.56 | 639.03 | 612.84 | 472.03 |
Common Stock | 0.07 | 0.07 | 0.07 | 0.07 | 0.06 |
Additional Paid-In Capital | 1,402 | 1,313 | 1,264 | 1,171 | 1,068 |
Retained Earnings | -1,253 | -1,048 | -951.8 | -729.19 | -634.6 |
Comprehensive Income & Other | 5.59 | -1.95 | 1.37 | -1.82 | -0.62 |
Shareholders' Equity | 155.17 | 263.1 | 313.63 | 439.95 | 433.11 |
Total Liabilities & Equity | 881.11 | 967.66 | 952.66 | 1,053 | 905.14 |
Total Debt | 449.38 | 478.37 | 420.37 | 424.58 | 314.67 |
Net Cash (Debt) | -156.71 | -40.04 | 47.55 | 192.32 | 309.14 |
Net Cash Growth | - | - | -75.28% | -37.79% | 20.47% |
Net Cash Per Share | -2.33 | -0.61 | 0.73 | 3.00 | 4.80 |
Filing Date Shares Outstanding | 68.33 | 66.47 | 65.63 | 64.53 | 63.87 |
Total Common Shares Outstanding | 68.29 | 66.26 | 65.55 | 64.51 | 63.83 |
Working Capital | 375.42 | 477.44 | 552.73 | 684.69 | 679.66 |
Book Value Per Share | 2.27 | 3.97 | 4.78 | 6.82 | 6.79 |
Tangible Book Value | 143.45 | 262.17 | 310.86 | 435.32 | 426.48 |
Tangible Book Value Per Share | 2.10 | 3.96 | 4.74 | 6.75 | 6.68 |
Machinery | 116.5 | 103.87 | 91.77 | 88.9 | 74.31 |
Leasehold Improvements | 40.13 | 37.11 | 37.57 | 35.83 | 25.25 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.